The clinical promise of 18F-flurpiridaz PET imaging heralds a new frontier in the diagnosis and management of coronary artery disease

Packard RRS. The clinical promise of 18F-flurpiridaz PET imaging heralds a new frontier in the diagnosis and management of coronary artery disease. Nat Cardiovasc Res. 2025 Jan;4(1):1-4. doi: 10.1038/s44161-024-00587-w. PMID: 39825085.


Related Posts